Stay updated on Nivolumab Ramucirumab Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ramucirumab Combo in NSCLC Clinical Trial page.

Latest updates to the Nivolumab Ramucirumab Combo in NSCLC Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.6.3 replaces the previous v3.6.2 on the page.SummaryDifference0.1%

- Check13 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, signaling a new page revision rather than changes to the study information.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now indicates recruitment is not ongoing and adds user-help sections (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention/Treatment label is reformatted and a Revision: v3.6.0 tag is applied.SummaryDifference0.5%

- Check34 days agoChange DetectedRevision label on the page updated from v3.5.4 to v3.5.5. This signals a new version of the ClinicalTrials.gov record was published.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page's study record dates were updated to add recent timestamps (2026-05-22, 2026-12, 2026-05-20, 2026-05) and remove older ones (2026-01-14, 2026-04, 2026-01-13, 2026-01). This reflects updates to the study timeline in the record.SummaryDifference0.3%

- Check55 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a newer revision of the page content. This change reflects an underlying update to the page as metadata rather than a modification to the visible study details.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Ramucirumab Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ramucirumab Combo in NSCLC Clinical Trial page.